A Novel Tool for the Generation of Conditional Knockouts To Study Gene Function across the Plasmodium falciparum Life Cycle. by Tiburcio, M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/208778
 
 
 
Please be advised that this information was generated on 2019-12-04 and may be subject to
change.
A Novel Tool for the Generation of Conditional Knockouts To
Study Gene Function across the Plasmodium falciparum Life
Cycle
Marta Tibúrcio,a Annie S. P. Yang,b Kazuhide Yahata,a,c Pablo Suárez-Cortés,e Hugo Belda,a Sebastian Baumgarten,d
Marga van de Vegte-Bolmer,b Geert-Jan van Gemert,b Youri van Waardenburg,b Elena A. Levashina,e Robert W. Sauerwein,b
Moritz Treecka
aSignalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, United Kingdom
bDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands
cDepartment of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan
dBiology of Host-Parasite Interactions Unit, Institut Pasteur, Paris, France
eVector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany
ABSTRACT Plasmodium falciparum has a complex life cycle that involves interaction
with multiple tissues inside the human and mosquito hosts. Identiﬁcation of essen-
tial genes at all different stages of the P. falciparum life cycle is urgently required for
clinical development of tools for malaria control and eradication. However, the study
of P. falciparum is limited by the inability to genetically modify the parasite through-
out its life cycle with the currently available genetic tools. Here, we describe the de-
tailed characterization of a new marker-free P. falciparum parasite line that expresses
rapamycin-inducible Cre recombinase across the full life cycle. Using this parasite
line, we were able to conditionally delete the essential invasion ligand AMA1 in
three different developmental stages for the ﬁrst time. We further conﬁrm efﬁcient
gene deletion by targeting the nonessential kinase FIKK7.1.
IMPORTANCE One of the major limitations in studying P. falciparum is that so far
only asexual stages are amenable to rapid conditional genetic modiﬁcation. The
most promising drug targets and vaccine candidates, however, have been refractory
to genetic modiﬁcation because they are essential during the blood stage or for
transmission in the mosquito vector. This leaves a major gap in our understanding
of parasite proteins in most life cycle stages and hinders genetic validation of drug
and vaccine targets. Here, we describe a method that supports conditional gene de-
letion across the P. falciparum life cycle for the ﬁrst time. We demonstrate its poten-
tial by deleting essential and nonessential genes at different parasite stages, which
opens up completely new avenues for the study of malaria and drug development.
It may also allow the realization of novel vaccination strategies using attenuated
parasites.
KEYWORDS Plasmodium falciparum, malaria, molecular methods, reverse genetic
analysis
Malaria is one of the world’s deadliest diseases, causing 219 million cases world-wide in 2017 and 435,000 deaths. Plasmodium falciparum is responsible for95%
of the reported cases (1). One of the greatest threats to malaria control is the emerging
resistance to all frontline drugs and the limited protection of the only approved
vaccine. Therefore, the development of novel drugs and vaccines becomes imperative
and urgent. A better understanding of the malaria parasite biology at each develop-
mental stage is fundamental and needed to accomplish this goal. This will lead to
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effective novel malaria interventions, which should target several of the parasite stages
in the human host, and many drug screens are targeted toward multistage activity (2,
3). Plasmodium parasites are transmitted by blood-feeding infected mosquitoes that
inject sporozoites into the human host. Sporozoites travel to the liver and invade
hepatocytes where they develop into thousands of merozoites that will be released
back into circulation. Once merozoites are in the bloodstream, they invade erythrocytes
and can either develop through a 48-h asexual cycle or develop sexually. The sexual
forms, the gametocytes, are the only stages that can mediate transmission through the
mosquito. Inside the mosquito, the gametocytes are activated, and fertilization occurs,
resulting in the formation of motile ookinetes that develop into oocysts, which then
develop into thousands of infective sporozoites.
One of the major bottlenecks when studying P. falciparum is the limited ability to
genetically modify the parasite in most life cycle stages, as the genetic tools for
identiﬁcation of essential genes across the P. falciparum life cycle are nonexistent (4). As
Plasmodium species are haploid during the asexual parasite stage when genetic
modiﬁcations are feasible, essential genes can be targeted only by conditional systems.
Several of these systems have been developed to allow downregulation of mRNA levels
(5–7), translation (8), proteins (9), or protein mislocalization (10). While the RNA and
protein regulation systems allow reversible control of protein levels, they can suffer
from background protein levels and require constant drug pressure. Conditional gene
deletions can be achieved using the FLP-frt system which has been developed to
conditionally test gene function during transmission in Plasmodium berghei and has
been adapted to P. falciparum (11). However, the requirement for stage-speciﬁc pro-
moters to drive recombinase activity at different life cycle stages severely limits its
usability in P. falciparum. A more reliable gene inactivation method is the rapamycin-
induced activation of dimerizable Cre recombinase (12). In combination with loxP sites
in artiﬁcial introns (loxPint), it allows rapid generation of ﬂoxed genetic elements for
gene truncations, deletions, domain replacements, and conditional introduction of
point mutations (13). All of these methods have been useful to study genes in the
erythrocytic stages of P. falciparum, but not for genes important for mosquito trans-
mission or liver stages, where such systems are highly needed.
In this study, we describe a novel parasite line that supports conditional gene
deletion in three different developmental stages and the study of essential genes
across the P. falciparum life cycle. This novel tool and approach can therefore be used
to investigate P. falciparum genes in most life cycle stages and genetically validate
novel multistage drug and vaccine candidates
RESULTS
Characterization of an NF54::DiCre line across the P. falciparum life cycle.
Rapamycin-induced activation of dimerized Cre recombinase has proven highly efﬁ-
cient in P. falciparum (12, 14–17). To enable conditional gene deletions at different time
points across the life cycle, we introduced a DiCre cassette into the pfs47 locus of NF54
parasites using CRISPR/Cas9, resulting in a marker-free NF54::DiCre parasite line (Fig. 1a
and b). Pfs47 was previously reported to play an important role during transmission in
Anopheles gambiae but not in Anopheles stephensi (18). We ﬁrst tested the NF54::DiCre
ability to develop across the P. falciparum life cycle (Fig. 1c). As expected, the NF54::
DiCre line shows no differences in growth compared to the parental line during asexual
and sexual development (data not shown) or infection of A. stephensi mosquitoes
(Fig. 1d and e). Moreover, sporozoites show normal invasion rates and development in
primary hepatocytes (Fig. 1f). To exclude any loss of genes caused by extended periods
of time in cell culture (19), we sequenced the genome of NF54::DiCre (BioProject
accession no. PRJNA422809) and found no differences from an NF54 isolate from a
different laboratory (see Fig. S1 in the supplemental material). These data suggest that
the NF54::DiCre parasite line can be efﬁciently used as a background to conditionally
delete genes across the life cycle.
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Rapamycin-mediated conditional truncation of AMA1 in asexual, gametocyte,
and hepatocyte stages. To test the recombination efﬁciency of the NF54::DiCre line at
different developmental stages, we generated a conditional knockout (KO) of the
blood-stage essential apical membrane antigen 1 (ama1) gene in the NF54::DiCre line.
AMA1 has been well characterized during asexual development in P. falciparum (20, 21),
but its role during transmission and hepatocyte invasion in different species is less well
understood (22–24). We inserted loxP sites in artiﬁcial introns (13) upstream of the
AMA1 transmembrane domain (TM) and downstream of its cytoplasmic tail, resulting in
a hemagglutinin (HA)-tagged AMA1 protein predicted to produce a soluble AMA1
isoform upon rapamycin treatment (20) (Fig. 2a). As expected, treatment of asexual
stages with rapamycin leads to truncation of ama1 and an inability to grow (Fig. 2b).
Efﬁcient loss of the HA tag was veriﬁed by immunoﬂuorescence assay, PCR, and
Western blotting (Fig. 2c and Fig. S2 and S3). Having conﬁrmed that deletion of the
AMA1 C terminus inactivates AMA1, we induced gene excision during sexual develop-
FIG 1 Generation and characterization of the NF54::DiCre line for conditional gene deletions across the P. falciparum life cycle. (a)
Schematics of the targeting (pBSPs47DiCre) plasmid, the expected recombination product, and representation of the primer pairs used
to test integration. (b) PCR analysis of DiCre cassette integration into the Pfs47 locus in P. falciparum NF54. The sequences of the primers
used (e.g., primer #151) are shown in Table S1 in the supplemental material. (c) Illustration of the P. falciparum life cycle and expected
timeline of the different developmental stages addressed in this paper. (d) Percentage of A. stephensi mosquitoes infected with NF54 and
NF54::DiCre after a blood meal, where each data point corresponds to the value from an independent experiment. (e) Number of NF54
and NF54::DiCre oocysts per mosquito gut. Each data point corresponds to the value from an independent experiment. (f) Comparison
of hepatocyte infection rates between NF54 and NF54::DiCre parasites of at least four independent experiments, each with two technical
replicates. All P values were calculated by the Mann-Whitney t test.
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FIG 2 Characterization of rapamycin-mediated excision efﬁciency of the AMA1 gene in the NF54::DiCre line across P. falciparum life cycle.
(a) Description of the strategy used to make the AMA1 conditional knockout (KO) line (AMA1:loxPint:HA) and the primers used to conﬁrm
integration. The rescue plasmid contains a recodonized version of the C-terminal ama1 gene (rc. AMA1), followed by a triple-HA (3xHA),
T2A peptide (2A), and neomycin resistance cassette (Neo-R), ﬂanked by loxPints. A GFP cassette is used to monitor rapamycin-mediated
excision events. (b) Growth curve comparing DMSO- and rapamycin-treated asexual parasites of two independent transfections
(populations A and B) representing two independent experiments. (c) Immunoﬂuorescence analysis of DMSO- and rapamycin-treated
asexual parasites from populations A and B using anti-HA antibody (-HA) to check for efﬁcient rapamycin-induced excision. (d)
Representation of the experimental workﬂow to test rapamycin-induced AMA1 KO during early sexual development. (e) Exﬂagellation
assays comparing male gametocyte exﬂagellation centers of DMSO- versus rapamycin-treated gametocytes (percent total mature
gametocytes). The data points represent the values for technical replicates from two independent experiments. (f) A. stephensi infection
rates comparing DMSO- versus rapamycin-treated AMA1:loxPint:HA gametocytes. Each data point corresponds to the value of an
independent experiment. (g) Average number of oocysts per mosquito midgut from DMSO- and rapamycin-treated AMA1:loxPint:HA
parasites. Each data point corresponds to the value of an independent experiment. (h) PCR analysis comparing DMSO- versus
rapamycin-treated parasite genomic DNA extracted from different developmental stages. Gametocytes were treated sequentially on days
6 and 7 after induction, sporozoites were treated either for 30 min (30’) or 4 hours (4h) at either 4°C or 37°C, and EEFs were treated for
(Continued on next page)
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ment by treating the parasites with rapamycin on days 6 and 7 after induction (Fig. 2d).
Phenotypic analysis of sexual development revealed no signiﬁcant difference in devel-
opment, exﬂagellation, or macrogamete formation rates between dimethyl sulfoxide
(DMSO)- and rapamycin-treated cultures (Fig. 2e and Fig. S4). The mature sexual
cultures were then fed to the A. stephensi mosquitoes. We observed a signiﬁcant
reduction of infected mosquitoes (43%) as well as a substantial reduction of oocyst
numbers (82.4%) in rapamycin-treated parasites compared with the DMSO control
(Fig. 2f and g). Analysis of the few resulting sporozoites for ama1 deletion efﬁciency by
immunoﬂuorescence revealed that 75% of all parasites showed loss of HA signal,
despite near complete excision of the locus during sexual stages, indicating some
positive selection for parasites during transmission that have functional AMA1 (Fig. 2h
and Fig. S5). Unfortunately, the low numbers of sporozoites obtained from the
rapamycin-treated gametocyte cultures prevented us from performing hepatocyte
invasion assays with AMA1 mutants. However, because the DMSO-treated parasites
transmitted well, we attempted to induce AMA1 truncations of isolated sporozoites
with rapamycin using different concentrations and incubation times (Fig. 2h). None of
the conditions tested resulted in recombination of the ama1 locus (Fig. 2h). We then
tested the possibility of conditionally deleting ama1 during liver-stage development
after sporozoite invasion (Fig. 2i). At 4 h postinfection (hpi), no excision could be
detected (data not shown). However, rapamycin treatment at 72 hpi resulted in efﬁcient
excision without affecting the development of exoerythrocytic forms (EEFs) develop-
ment (Fig. 2h and j). Immunoﬂuorescence and PCR analyses showed complete loss of
HA signal and excision of the ﬂoxed DNA, respectively, in EEFs after 7 days of devel-
opment (Fig. 2h and j). While further work is required to pinpoint the role of AMA1
during transmission, these data show that efﬁcient rapamycin-mediated gene deletion
can be achieved in asexual, sexual, and liver stages using an NF54::DiCre line.
FIKK7.1 conditional KO characterization across the P. falciparum life cycle.
Because of the unexpected phenotype of AMA1 during transmission, we wanted to
conﬁrm that rapamycin treatment itself has no effect on transmission. To do so, we
generated a conditional KO line of FIKK7.1 (PF3D7_0726200), a nonessential blood-
stage kinase, in the NF54::DiCre line (25). We ﬂanked the ﬁkk7.1 kinase domain with
loxPints (13) and used a selection-linked integration (SLI) method to select for integra-
tion (10) (Fig. 3a). To understand whether gene deletion during sexual development
was affecting mosquito infection, we conditionally deleted ﬁkk7.1 during sexual devel-
opment (Fig. 3b). The rapamycin-treated gametocytes were grown to maturity and
then fed to A. stephensi to evaluate transmission efﬁciency. Rapamycin treatment of the
FIKK7.1:loxPint:HA gametocytes showed efﬁcient excision of the ﬂoxed locus, as ex-
pected (Fig. 3b). DMSO- and rapamycin-treated parasites showed no differences in the
number of infected mosquitoes (Fig. 3c), although rapamycin treatment resulted in a
modest but signiﬁcant reduction (21%) of oocyst loads (Fig. 3d). Sporozoites from both
conditions were then extracted from the mosquito salivary glands and used for PCR
analysis and invasion assays (Fig. 3e and f). Genomic DNA analysis showed some
background excision in the DMSO condition, while highly efﬁcient excision of the
ﬁkk7.1 kinase domain was detected in rapamycin-treated cultures (Fig. 3e). Isolated
sporozoites showed normal hepatocyte invasion rates (Fig. 3f) and development of
EEFs (Fig. 3g and h) when comparing NF54 and FIKK7.1:loxPint:HA DMSO- and
rapamycin-treated parasites.
To better understand whether the observed reduction in oocyst numbers was due
to rapamycin treatment or indeed FIKK7.1 speciﬁc, we treated NF54 gametocytes with
DMSO or rapamycin and compared parasite infectivity to mosquito infectivity and
number of oocysts. This analysis showed no difference in mosquito infection rates;
FIG 2 Legend (Continued)
24 h or 48 h. The sequences of the primers used are shown in Table S1. (i) Description of DMSO and rapamycin treatment point for
conditional gene deletion during hepatocyte development. (j) Immunoﬂuorescence analysis of EEFs on day 7 after hepatocyte infection
comparing DMSO versus rapamycin treatment. All P values were calculated by the Mann-Whitney t test.
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FIG 3 Generation and characterization of a FIKK7.1:loxPint:HA conditional KO across the P. falciparum life cycle. (a) Description of the
strategy used to make an FIKK7.1 conditional KO line (FIKK7.1:loxPint:HA). The rescue plasmid contains a recodonized version of FIKK7.1
kinase domain followed by a triple-HA, T2A peptide, and neomycin resistance cassette, ﬂanked by loxPints. A GFP cassette is inserted to
facilitate efﬁcient excision events. The primer pairs represented here were used to test correct integration of FIKK7.1:loxPint:HA, and
efﬁcient rapamycin-mediated excision and can be found in Table S1. (b) PCR analysis shows correct integration of FIKK7.1:loxPint:HA and
near complete excision of FIKK7.1 kinase domain after rapamycin treatment. (c) Infection rates in A. stephensi fed DMSO- or rapamycin-
treated FIKK7.1:loxPint:HA gametocytes. Each data point represents the value for an independent experiment. (d) Mean number of oocysts
per mosquito gut resulting from DMSO- or rapamycin-treated FIKK7.1:loxPint:HA parasites where each data point represents the value
from an independent experiment. (e) PCR analysis of sporozoites isolated from mosquitoes infected with DMSO- or rapamycin-treated
gametocytes. (f) Hepatocyte infection rates comparing uninfected, NF54, and DMSO- and rapamycin-treated FIKK7.1:loxPint:HA parasites.
(Continued on next page)
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however, a 30% reduction of oocysts in rapamycin-treated parasites compared to
DMSO-treated parasites was observed (Fig. 3i and j). Although the variation in the
oocyst numbers was high and the differences were not statistically signiﬁcant, we
observed a trend, which is discussed further below.
These results showed that efﬁcient rapamycin-mediated gene deletion can be
achieved in sexual stages without substantially impacting later stages of parasite
development. Furthermore, we conﬁrmed a nonessential role of FIKK7.1 throughout
the P. falciparum life cycle and that genetically modiﬁed and rapamycin-treated para-
sites can be transmitted by mosquitoes and infect hepatocytes.
Anopheles gambiae TEP1 knockdown can be infected with NF54::DiCre. It has
been shown previously that Pfs47-KO parasites fail to infect A. gambiae mosquitoes
because of efﬁcient ookinete killing by the mosquito complement-like protein TEP1 (26,
27). We reasoned that depletion of the TEP1 protein in A. gambiae would also expand
the usability of the NF54::DiCre strain in this mosquito species. To test the infectivity of
NF54::DiCre in A. gambiae, we used a transgenic immunodeﬁcient mosquito line
depleted for TEP1 (28). NF54::DiCre parasites efﬁciently infected A. gambiae 7b mos-
quitoes and produced similar oocyst numbers to the parental NF54 parasites (Fig. 3k
and l). We concluded that NF54::DiCre line can be used to infect A. gambiaemosquitoes.
Similar to A. stephensi infections, rapamycin-treated parasites did not show any differ-
ence in prevalence of infection (Fig. 3k), but they displayed lower oocyst numbers (30%
lower) compared to DMSO controls (Fig. 3l). However, the observed differences were
not statistically signiﬁcant, probably due to high variability between mosquito infection
experiments (Fig. 3l). These results show that the NF54::DiCre line can be used for
infection of A. gambiae species in complement-depleted mosquitoes. However, the
observed effect of rapamycin treatment on oocyst loads calls for further investigation.
DISCUSSION
The availability of genetic tools to manipulate P. falciparum is fundamental in the
study of malaria and identiﬁcation of novel drug targets. By introducing a DiCre
cassette into the pfs47 locus of NF54 parasites using CRISPR/Cas9, we created a
marker-free NF54::DiCre parasite line that develops through the P. falciparum life cycle
up to the stage of hepatocyte development. Our study introduces a novel tool and
methodology that allows for the ﬁrst time the conditional deletion of essential genes
during sexual and liver stages in human malaria parasites. To validate the use of this
tool, we made an AMA1 conditional KO line to truncate the gene at different develop-
mental stages. AMA1 is a microneme protein that plays a critical role during erythrocyte
invasion, and due to its essential role during asexual growth, it cannot be genetically
disrupted by conventional methods. AMA1 is also abundantly expressed in sporozoites;
however, the role of AMA1 during hepatocyte invasion is contradictory. While stage-
speciﬁc promoter-driven conditional disruption of AMA1 in the rodent malaria parasite
P. berghei had no effect on cell traversal activity or hepatocyte invasion (22), invasion
of P. falciparum sporozoites was drastically reduced upon incubation with the anti-
AMA1 monoclonal antibodies or the AMA1 inhibitory peptide R1 (23, 24). Using a
conditional KO, we aimed to address the role of AMA1 during hepatocyte invasion.
However, an unexpected signiﬁcant reduction of oocyst (82%) and sporozoite numbers
in rapamycin-treated parasites made these experiments impossible. The basis for this
FIG 3 Legend (Continued)
The data points represent the values for technical replicates of one experiment. (g) Immunoﬂuorescence analysis of sporozoite
development in human hepatocytes. Anti-HSP70 antibodies were used to identify and compare the EEFs at day 5 postinvasion. (h)
Measurement of the area of EEFs on day 5 postinvasion, where each EEF from two independent experiments is represented. (i) Infection
rates in A. stephensi mosquitoes fed DMSO- or rapamycin-treated NF54 gametocytes. Each data point represents the value from an
independent experiment. (j) Mean number of oocysts per mosquito gut resulting from DMSO- or rapamycin-treated NF54 parasites where
each data point represents the value for an independent experiment. (k) Infection rates in A. gambiae fed DMSO- or rapamycin-treated
NF54::DiCre gametocytes. Each data point represents the value from an independent experiment. (l) Mean number of oocysts per A.
gambiae mosquito gut resulting from DMSO- or rapamycin-treated NF54::DiCre parasites. Each data point represents the value from an
independent experiment. All P values were calculated by the Mann-Whitney t test.
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reduction is currently unknown. No AMA1 has been identiﬁed in the P. berghei ookinete
proteome (29, 30), and no P. falciparum ookinete proteome data are available as a
comparison. In line with micronemes and microneme-produced proteins being present
in all invasive zoite forms, including ookinetes, transcriptomic data revealed an up-
regulation of AMA1 in ookinetes (31). In light of our results, it is possible that AMA1
regulates P. falciparum ookinete invasion in mosquitoes. However, further work is
required to explore a putative role of AMA1 during mosquito transmission.
To examine the effect of rapamycin treatment on the transmissible forms of P.
falciparum, we generated a FIKK7.1 conditional KO line. We predicted that FIKK7.1 is not
required for parasite development in mosquitoes. However, rapamycin treatment of the
parasites during sexual development in vitro reduced the mean oocyst numbers in the
midguts of A stephensi mosquitoes. While the observed differences for FIKK7.1 were
statistically signiﬁcant, a similar mean decrease in oocyst numbers were observed in
rapamycin-treated control NF54 P. falciparum parasites in A. stephensi and A. gambiae
infections, providing a possible explanation for the FIKK7.1 KO phenotype. However,
the FIKK7.1 KO data differed from the AMA1 KO data, which showed a signiﬁcant
fourfold reduction in oocyst numbers, indicating that rapamycin treatment per se is not
responsible for the AMA1 phenotype within mosquito parasite development. Moreover,
rapamycin treatment did not affect the percentage of infected mosquitoes, whereas a
strong signiﬁcant reduction was observed in infection prevalence for AMA1 KO line.
Rapamycin treatment did not affect either the hepatocyte infection rate or the size of
extraerythrocytic forms, indicating that it does not curb the transmission of the
NF54::DiCre parasites in general.
In summary, we show that the NF54::DiCre parasite lines can be used to generate
conditional KOs of essential and nonessential genes in different developmental stages
and assess their role throughout the P. falciparum life cycle. We have not tested
whether deletion of genes can be achieved during the mosquito phase, for example by
feeding mosquitoes with rapamycin. Such experiments will require very careful analysis
because of potential toxic effects of the mTOR (mammalian target of rapamycin)
inhibitor rapamycin on mosquito physiology. However, the ability to delete genes in
gametocytes and hepatocytes should generate unprecedented insights into the biol-
ogy and drug target validation across parasite stages. The ability to delete blood-stage
essential genes, such as ama1, in sexual or liver-stage parasites may also enable the
generation of late-stage arrested attenuated parasites for clinical vaccine development.
We believe that this tool will promote substantial advancements in research of trans-
mission and liver stages and will therefore open up new avenues for the study of one
of the world’s deadliest diseases.
MATERIALS AND METHODS
Plasmodium falciparum in vitro culture of asexual and sexual blood stages. The Plasmodium
falciparum parasite lines used in this study were all derived from the NF54 strain (originally isolated from
an imported malaria case in the Netherlands in the 1980s) (BEI Resources catalog no. MRA-1000) (32).
Asexual parasites were cultured in human blood (UK National Blood Transfusion Service) and RPMI 1640
medium containing 0.5% (wt/vol) AlbumaxII (Invitrogen) at 37°C as previously described (33). Asexual
parasites were used to produce gametocytes by seeding asexual rings at 1% parasitemia and 4%
hematocrit on day 0 and feeding the parasites once a day during 15 days (day 0 to day 14) in 3% O2–5%
CO2–92% N2 gas in RPMI 1640 medium complemented with 25 mM HEPES, 50 mg/liter hypoxanthine, 2
g/liter sodium bicarbonate, and 10% human serum (34).
Conditional knockout (KO) induction at different P. falciparum developmental stages. To
induce DiCre-driven loxP site recombination, synchronized ring-stage parasites were treated with 100 nM
rapamycin (Sigma) or dimethyl sulfoxide (DMSO) (0.1% [vol/vol]) for 18 h. Parasites were subsequently
washed twice with RPMI 1640 medium and returned to culture. Schizonts used for PCR, immunoﬂuo-
rescence assay (IFA), or protein extraction were taken 38 to 41 h after rapamycin or DMSO treatment. The
rapamycin-induced recombination in early sexual stages was accomplished by treating the parasites with
100 nM rapamycin or DMSO for 4 h on day 6 and on day 7 during sexual induction. The parasites were
subsequently washed in RPMI 1640 medium and used for further analysis or mosquito feeding on day
14. During liver development, the exoerythrocytic forms (EEFs) were treated with 100 nM rapamycin 72 h
after invasion for 24 h and sequentially washed with culture medium.
Exﬂagellation assay. As previously described, sexual induction starts on day 0 by seeding asexual
rings at 1% parasitemia (34). On day 14, male exﬂagellation was induced by adding 5 l of ookinete
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medium (RPMI 1640 supplemented with 25 mM HEPES, 50 gml1 hypoxanthine, 2 g liter1 NaHCO3,
and 100 M xanthurenic acid) to a 100-l sample of gametocyte culture in a 96-well plate (34). Twenty
minutes after gamete activation, exﬂagellation was recorded by bright-ﬁeld microscopy using a Nikon
Eclipse Ti wide-ﬁeld inverted microscope using a 4 objective, 1.5 zoom, recording a 10-frame video
time-lapse over 2 s for each well, as previously described (32). Two independent experiments, each with
at least three technical replicates, were used per condition. Exﬂagellation was quantiﬁed using the
open-source ICY Image Analysis software (35). The Mann-Whitney t test was used for calculating
statistical signiﬁcance (P  0.05).
Standard membrane feeding assay. For the standard membrane feeding assay (SMFA) experiments
in Anopheles stephensi, sexual development was induced by seeding asexual rings at 1% parasitemia and
5% hematocrit (O red blood cells from healthy Dutch blood bank donors without any history of malaria)
in RPMI 1640 with HEPES (5.94 g/liter), hypoxanthine (0.05 g/liter]), 10% human serum, and 5%
bicarbonate (42 ml/liter) and cultured in an automated tipper system (36, 37) and changing the medium
twice a day for 14 days. On day 14, the cultures containing mature gametocytes were used for the SMFA
as previously described (38). For SMFA on Anopheles gambiae 7b mosquitoes (28), parasites were grown
in culture ﬂasks on O human red blood cells (Haema, Berlin, Germany). Sexual development was
induced by seeding parasites at 4% parasitemia and daily medium changes. Rapamycin (100 nM) or
DMSO (0.1%) treatments were applied for 24 h on day 3 after seeding, corresponding to I-II stage
gametocytes in vitro. Infections were done on day 12 after seeding. Mosquitoes were fed for 15 min on
a membrane feeder with the gametocytes and kept in a secured S3 laboratory according to the national
regulations (Landesamt für Gesundheit und Soziales, project 411/08). Unfed mosquitoes were removed
after feeding, and fed mosquitoes were maintained at 26°C until dissected for oocyst count.
Isolation and puriﬁcation of P. falciparum sporozoites. Fourteen to 21 days postinfection of
female A. stephensi mosquitoes, the salivary glands were hand dissected, collected in complete William’s
B medium (see “Isolation and culture of human hepatocytes” below), and homogenized in a homemade
glass grinder. Sporozoites were counted in a Burker-Turk counting chamber using phase-contrast
microscopy (39).
Isolation and culture of human hepatocytes. Primary human hepatocytes were prepared from liver
segments taken from adult patients during liver surgery, in agreement with Dutch ethical regulations.
Hepatocytes were isolated by using the two-step enzymatic perfusion technique (40). The liver tissue was
perfused via any vessel (venous or portal vein) with 500 ml of HBSS medium (Gibco catalog no.
14170-088) supplemented with 10 mM HEPES (Gibco catalog no. 15630-056) and 0.64 mM EDTA (Invit-
rogen catalog no. 15575-038). Subsequent perfusion was performed with 500 ml of HBSS medium
supplemented with 10 mM HEPES and with 100 ml of oxygenized HBSS medium supplemented with
10 mM HEPES, 0.75 mg/ml CaCl2, and low concentrations of collagenase (3,333 U per 50 ml). Next, the
tissue was perfused with 100 ml of oxygenized HBSS medium supplemented with 10 mM HEPES,
0.75 mg/ml CaCl2, and high concentrations of collagenase (13,333 U per 50 ml). This buffer was recircu-
lated until liver tissue became very soft. Subsequently, the liver tissue was transferred into a petri dish
containing 40 ml cold DMEM medium (Gibco catalog no. 31885-023) supplemented with 10% fetal
bovine serum (FBS) (Gibco catalog no. 10270). The liver tissue was cut into small pieces to extract cells
for a single-cell suspension of hepatocytes. This primary human hepatocyte suspension was centrifuged
at 10 g with low brake for 5 min at 4°C. Hepatocyte pellets were washed in Dulbecco modiﬁed Eagle
medium (DMEM) without serum and again centrifuged at 50 g with low brake for 5 min at room
temperature. This step was repeated until the supernatant looked clear. Viable cells were separated from
dead cells using Percoll puriﬁcation (ﬁnal concentration of 28.8% [vol/vol]), and the pellet was resus-
pended in complete William’s B medium, consisting of William’s E medium with Glutamax (Gibco catalog
no. 32551-087) supplemented with 10% heat-inactivated human serum, 1% insulin-transferrin-selenium
(Gibco catalog no. 41400-045), 1% sodium pyruvate (Gibco catalog no. 11360-036), 1% minimum
essential medium nonessential amino acids (MEM-NEAA) (Gibco catalog no. 1140-035), 1% amphotericin
B (Fungizone) antimycotic (Gibco catalog no. 15290-018), 2% penicillin-streptomycin (Gibco catalog no.
15140-122), and 1.6 M dexamethasone. Hepatocytes (260,000 cells/coverslip) were plated on collagen-
coated 12-cm wells at 37°C in an atmosphere of 5% CO2, and the medium was refreshed the next
morning (500 l/well complete William’s B medium) and then every 2 days.
Standard sporozoite infectivity assay. Fresh human hepatocytes were seeded in 24-well culture
plates (250,000 cells/well) and incubated at 37°C for 48 h before inoculation with P. falciparum sporo-
zoites. Sporozoites in culture medium were added to the wells and coincubated with the conﬂuent
human hepatocytes (1 sporozoite:1 hepatocyte) for 3 h at 37°C (for sporozoite invasion). After 3 h, the
wells were washed to remove sporozoites that have not invaded hepatocytes and then incubated at 37°C
with daily medium refreshment for 7 days to obtain liver schizonts.
Nested PCR. The sporozoite’s genomic DNA (gDNA) for genotype analysis was extracted using a
Qiagen DNeasy blood and tissue kit. The ﬁrst PCR was done using primers F0 and R1 (see Table S1 in the
supplemental material) and OneTaq 2Master Mix (NEB). Five microliters of the ﬁrst PCR were then used
as a template for a second pair of primers, primers #420 and #423 (Table S1), and a second ampliﬁcation
step using OneTaq 2 Master Mix (NEB).
Western blotting. Schizonts were released from erythrocytes by the addition of phosphate-buffered
saline (PBS) containing 0.15% (wt/vol) saponin and protease inhibitors (cOmplete EDTA-free; Sigma) for
3 min on ice. Saponin lysates were solubilized with 3 sample buffer with 5% beta-mercaptoethanol at
a concentration of 1.6 109 parasites/ml. Parasite extracts were subjected to SDS-PAGE and transferred
to a nitrocellulose membrane. Membranes were immunostained with rat antihemagglutinin (anti-HA)
(1:1,000 dilution; Roche) and rabbit anti-P. falciparum EBA175 (anti-PfEBA175) (1:2,000 dilution; a kind gift
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from Christine R. Collins), followed by IRDye 680LT goat anti-rat IgG (1:10,000 dilution; LI-COR) and IRDye
800CW goat anti-rabbit IgG (1:10,000 dilution; LI-COR). The signals were detected by a ﬂuorescence
imager (Odyssey CLx; LI-COR).
Immunoﬂuorescence assay at different parasite stages. Air-dried blood ﬁlms of asexual parasites
were ﬁxed with 4% paraformaldehyde containing 0.0075% glutaraldehyde for 15 min and permeabilized
in 0.1% (vol/vol) Triton X-100 (Sigma) for 10 min. Blocking was performed in 3% bovine serum albumin
(BSA) for 1 h. Slides were incubated with rat anti-HA (1:1,000 dilution; Roche) at room temperature for
30 min, followed by Alexa Fluor-conjugated goat anti-rat IgG (1:1,000 dilution) at room temperature for
30 min. Parasite nuclei were stained with 4=,6=-diamidino-2-phenylindole (DAPI) (Invitrogen). Slides were
mounted with ProLong Gold antifade reagent (Invitrogen), and images were obtained with the inverted
ﬂuorescence microscope (Ti-E; Nikon, Japan) and processed using NIS-Elements software (Nikon, Japan).
Sporozoites were extracted from the salivary glands of A. stephensi mosquitoes, ﬁxed in 4% para-
formaldehyde, permeabilized with 1% Triton X-100, and stained using rabbit anti-HSP70 (StressMarq
SPC-186 used at 1:75 dilution), and rat anti-HA (Sigma-Aldrich catalog no. 11867423001) (used at 1:500
for 1 h at room temperature). All secondary antibodies were used at 1:200 dilution and incubated for 1 h
at room temperature: goat anti-rat secondary antibody conjugated to Alexa Fluor 594 (goat anti-rat Alexa
Fluor 594) (ThermoFisher catalog no. A-11007) and donkey anti-rabbit Alexa Fluor 647 (ThermoFisher
catalog no. A-31573). The staining is completed with DAPI staining (ThermoFisher catalog no. D1306) and
rabbit anti-green ﬂuorescent protein (anti-GFP) (ThermoFisher catalog no. A-21311; used at 1:200) for 1 h
in 1 PBS and mounted using Vectashield (Vector Laboratories catalog no. H-1000). Infected hepatocytes
were ﬁxed on day 5 or 7 postinvasion and permeabilized as mentioned above. The EEFs were then
stained using rabbit anti-HSP70 (StressMarq SPC-186 used at 1:75 dilution), rat anti-HA (Sigma-Aldrich
catalog no. 11867423001; used at 1:500), and mouse anti-MSP1 (Sanaria AD233; 1:100) for 1 h at room
temperature. All secondary antibodies were used at 1:200 dilution and incubated for 1 h at room
temperature: donkey anti-mouse Alexa Fluor 694 (ThermoFisher catalog no. A-31571), goat anti-rat Alexa
Fluor 594 (ThermoFisher catalog no. A-11007), and chicken anti-rabbit Alexa Fluor 488 (ThermoFisher
catalog no. A-21441). All secondary antibodies were used at 1:200 dilution and incubated for 1 h at room
temperature: goat anti-rat Alexa Fluor 594 (ThermoFisher catalog no. A-11007) and donkey anti-rabbit
Alexa Fluor 647 (ThermoFisher catalog no. A-31573). The staining is completed with DAPI staining
(ThermoFisher catalog no. D1306) for 1 h in 1 PBS and mounted using Vectashield (Vector Laboratories
catalog no. H-1000). For both sporozoite and hepatic stages, the coverslips are tile scanned (9 9) using
the Leica DM16000B automated high-content microscope with a 20 objective. The resulting number
of EEFs and DAPI-stained cells were counted; the infection rate is the percentage of hepatocytes that has
an intracellular parasite. High-resolution microscopy was performed with the Zeiss LSM880 with Airyscan
at 63 oil objective.
SUPPLEMENTAL MATERIAL
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FIG S2, TIF ﬁle, 0.5 MB.
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